Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
- IPro for Benlysta, Pulver zur Herstellung einer Infusionslösung (120 mg oder 400 mg)
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Information for professionals for Benlysta, Pulver zur Herstellung einer Infusionslösung (120 mg oder 400 mg):
GlaxoSmithKline AG
Complete information for professionals
DDD
Änderungen anzeigen
Print
Composition.
Galenic Form
Indication.
Usage
Contra Indication
Warning restrictions.
Interactions.
Pregnancy
Driving ability
Unwanted effects
Overdose
Effects
Pharm.kinetik
Preclinical
Other advice
Swissmedic-Nr.
Packages
Registration owner
Last update of information
Stand der Information
September 2024
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home